|
The ALS Society of Canada is a registered, not-for-profit Canadian organization. ALS Canada, founded in 1977, is a national voluntary health organization dedicated to the fight against amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and to providing support for those living with ALS. ALS Canada is committed to supporting research towards a cure for ALS, supporting the provincial ALS societies in their provision of quality care for persons living with ALS, and building public awareness of ALS and its impact. ==Research== The mission of the ALS Society of Canada is to fund research for a cure for ALS. Since 2000, ALS Canada has been one of the partners of the Neuromuscular Research Partnership (NRP), which is a collaboration between the Canadian Institutes of Health Research (CIHR), Muscular Dystrophy Canada (MDC) and ALS Canada. The NRP makes grants available for research into the causes, treatments, and ultimately the cure for neuromuscular disorders. ALS Canada is currently funding a national clinical trial, which aims to confirm the effectiveness of lithium in slowing the progression of ALS in patients in the early stages of the disease. At nearly $1,000,000, the lithium trial is ALS Canada’s largest research investment to date. The lithium trial is being conducted by a consortium of ALS clinicians in Canada called the Canadian ALS Clinical Trials and Research Network (CALS). The trial is the first joint effort between CALS and the Northeastern ALS Consortium (NEALS) in the United States. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「ALS Society of Canada」の詳細全文を読む スポンサード リンク
|